“President Biden’s historic Inflation Reduction Act finally allowed Medicare to negotiate lower drug prices for millions of seniors and other beneficiaries – despite zero Republicans in Congress supporting it and Big Pharma spending hundreds of millions of dollars to prevent that from happening.
October 3, 2023
As part of its ongoing work to make sure all Americans have access to health care coverage, the U.S. Department of Health and Human Services, through the Centers for Medicare & Medicaid Services (CMS), sent a letter to state health officials reinforcing that states must provide 12 months of continuous coverage for children under the age of 19 on Medicaid and the Children’s Health Insurance Program (CHIP) beginning January 1, 2024.
October 2, 2023
The Centers for Medicare & Medicaid Services (CMS) announced that average premiums, benefits, and plan choices for Medicare Advantage and the Medicare Part D prescription drug program will remain stable in 2024. Improvements adopted in the 2024 Rate Announcement, as well as the 2024 Medicare Advantage and Part D Final Rule, such as increased beneficiary protections around marketing and prior authorization and increased access to behavioral health, support this stability.
September 28, 2023
As part of the U.S. Department of Health and Human Services (HHS) Maternal Health Day of Action, HHS Secretary Xavier Becerra announced several new actions to address the nation’s longstanding maternal health crisis. Secretary Becerra hosted a roundtable with the Health Resources and Services Administrator Carole Johnson as well as providers, advocacy organizations, and state and local leaders in Baltimore, Maryland.